AVITA Medical is a regenerative medicine company focused on the development and commercialization of innovative therapies with the power to transform lives. Harnessing the regenerative properties of a patient’s own skin, AVITA Medical’s RECELL® System was approved by the U.S. Food and Drug Administration (FDA) in September 2018.

 


RECELL® System


Avita Medical Recell Product

The RECELL® System is the first new PMA-approved treatment in more than 20 years for acute thermal burn wounds in patients 18 years of age and older.

Clinical Outcomes


Avita Medical Clinical Outcome

We’re elevating the standard of care for the treatment of skin restoration.

Pipeline


We’re exploring the potential of this novel technology platform to harness the regenerative properties of a patient’s own skin across a number of dermatological indications.

At AVITA Medical, patients are at the center of what we do. They guide and inspire our tireless dedication to advance bold innovation in regenerative medicine to deliver medical outcomes that transform lives.

News Highlights

PRESS RELEASE | SEPTEMBER 16, 2020
Change of Director's Interest Notice - Michael Perry

PRESS RELEASE | SEPTEMBER 16, 2020
Appendix 3G


How the RECELL® System Works

This website stores cookies on your computer. These cookies are used to improve your website experience and provide more personalized services to you, both on this website and through other media. To find out more about the cookies we use, see our privacy policy.